metformin has been researched along with Drug-Induced Cochlear Toxicity in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, P | 1 |
| Liu, T | 1 |
| Luo, P | 1 |
| Li, H | 1 |
| Tang, W | 1 |
| Zong, S | 1 |
| Xiao, H | 1 |
| Liang, Z | 1 |
| Zhang, T | 1 |
| Zhan, T | 1 |
| Cheng, G | 1 |
| Zhang, W | 1 |
| Jia, H | 1 |
| Yang, H | 1 |
2 other studies available for metformin and Drug-Induced Cochlear Toxicity
| Article | Year |
|---|---|
SIRT3/GLUT4 signaling activation by metformin protect against cisplatin-induced ototoxicity in vitro.
Topics: Antineoplastic Agents; Apoptosis; Cisplatin; Humans; Metformin; Ototoxicity; Sirtuin 3 | 2023 |
Metformin alleviates cisplatin-induced ototoxicity by autophagy induction possibly via the AMPK/FOXO3a pathway.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents; Autophagy; Cells, Cultured; Ci | 2021 |